Lithium and clozapine-induced neutropenia/agranulocytosis

International Clinical Psychopharmacology

Volumn 13, Issue 3, 1998, Pages 137-140

  Blier, R ^a   Slater, S ^a   Measham, T ^a   Koch, M ^a   Wiviott, G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Agranulocytosis; Clozapine; Lithium; Neutropenia; Side effects

Indexed keywords

CLOZAPINE; LITHIUM;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; FEMALE; GRANULOPOIESIS; HUMAN; LEUKOCYTE COUNT; NEUTROPENIA; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 7344253543     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199805000-00008     Document Type: Article

References (16)

1. Alvir JMJ, Lieberman JA (1994). A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience. J Clin Psychopharmacol 14:87-89.
2. Barnas C, Zwierzina H, Hummer M, Sperner-Unterweger B, Stern A, Fleischhachker WW (1992). Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report. J Clin Psychiatry 53:245-247.
3. Barrett AJ (1980). Haematological effects of lithium and its use in the treatment of neutropenia. Blut 40:1-6.
4. Gerson SL, Gullion, Yeh H-S, Masor C (1992). Granulocyte colony-stimulating factor for clozapine induced agranulocytosis. Lancet 340:1097.
5. Idänpään-Heikkilä J, Alhava E, Olkinuora M (1977). Agranulocytosis during treatment with clozapine. Eur J Clin Pharmacol 11:193-198.
6. Liberman JA, Alvir JMJ (1992). A report of clozapine-induced agranulocytosis in the United States: Incidence and risk factors. Drug Safety 7:1-2.
7. Mayfield D, Brown RG (1996). The clinical laboratory and electroencephalographic effects of lithium. J Psychiat Res 4:207-219.
8. Mendelowitz AJ, Gerson SL, Alvir JMJ, Lieberman JA (1995). Clozapine-induced agranulocytosis CNS Drugs 4:412-421.
9. Murphy DL, Goodwin FK, Bunney WE (1971). Leukocytosis during lithium treatment. Amer J Psychiat 127:1559-1561.
10. Nielsen H (1993). Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis. J Internal Med 234:529-531.
11. Oren R, Granat E, Shtrussberg S, Matzner Y (1993). Clozapine-induced agranulocytosis treated with granulocyte macrophage colony stimulating factor. Br J Psychiatry 162:686-687.
12. Pisciotta A, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA (1992). Cytoxic activity in patients with clozapine-induced agranulocytosis. J Lab Clin Med 149:252-266.
13. Rothstein G, Clarkson DR, Larsen W, Grosser BI, Athens JW (1978). Effect of lithium on neutrophil mass and production. New Engl J Med 298:178-180.
14. Silverstone PH (1998). Prevention of clozapine-induced neutropenia by pretreatment with lithium. J Clin Psychopharmacol 18:86-88.
15. Stein RS (1978). Lithium-induced granulocytosis. Annals Int Med 88:809-810.
16. Weide R, Koppler H, Heymanns J, Pfluger KM, Havemann K (1992). Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br J Haematol 80:557-559.